ReviewFrontiers in oncology2026
Artificial intelligence and its application in early oral cancer screening: a systematic review.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Global, regional, and national burden of oral cancer from 1990 to 2021: Analysis of risk factors and prediction of trends in 2050.Medicine · 2026Article
- Article
- A Pilot Study of the Diagnosis of Oral Cancer Through the Development of an AI Application.Dentistry journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral cancer is a globally prevalent and life-threatening malignancy, where early detection can significantly improve prognosis and reduce mortality. Traditional screening methods are often limited by operator dependence, invasiveness, and high costs, leading to frequent late diagnoses. This systematic review aims to evaluate the current application of artificial intelligence (AI) technology in the early diagnosis and risk prediction of oral cancer, with a focus on diagnostic accuracy, methodological diversity, and clinical translatability.
methodsWe conducted a systematic search across five databases (PubMed, Embase, Cochrane Library, Web of Science, and Scopus), incorporating 63 high-quality studies. The analysis was performed at two levels: data input modalities and the evolution of AI algorithms. Study selection, data extraction, and quality assessment followed standard systematic review protocols.
resultsAI models demonstrated high sensitivity and specificity in detecting early oral lesions and differentiating precancerous lesions, showing a trend toward multimodal fusion, lightweight, and high-performance development. However, most studies faced challenges such as insufficient sample sizes, limited external validation, and poor model interpretability.
conclusionAI holds significant potential for improving early oral cancer screening. To fully realize its clinical value, it is essential to establish large-scale multicenter datasets, conduct rigorous prospective validation, enhance model transparency, and address ethical and privacy concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.